What's new

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised

May 14, 2025 - 14:18
 0
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir...

Next Article

Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine ...

Related Posts

EMA/FVE info session for veterinary practitioners : Understanding the first report of sales and use of antimicrobials in animals, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2024, 15:30 (CEST) to 3 June 2024, 16:30 (CEST)

EMA/FVE info session for veterinary practitioners : Und...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

PMF dossier requirements - Questions and answers for PM...

May 14, 2025  0